Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Carcinoma, Non-Small-Cell Lung 13Neoplasm Metastasis 10Carcinoma, Medullary 10Thyroid Neoplasms 5Lung Neoplasms 5Prostatic Neoplasms 3Neoplasms 3Adenocarcinoma 3Familial medullary thyroid carcinoma 2Colorectal Neoplasms 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Recurrence 1Rectal Neoplasms 1Pleural Effusion 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Mesothelioma 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Differentiated Thyroid Cancer 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Large Cell 1Carcinoma, Hepatocellular 1Carcinoma 1Biliary Tract Neoplasms 1Aggression 1Advanced Breast Cancer 1

Interventions

vandetanib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Familial medullary thyroid carcinoma × vandetanib × Clear all
NCT00410761 2025-09-24

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

Sanofi

Phase 3 Completed
331 enrolled 15 charts
EndocrineHead & Neck

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

NCT00358956 2017-01-30

A Study To Assess ZD6474 (ZACTIMAâ„¢) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Sanofi

Phase 2 Completed
19 enrolled 10 charts
EndocrineHead & Neck

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡